
What is the Johnson&Johnson Patient Assistance Foundation?
Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)* is committed to helping you get the prescription medications you need. If you qualify, the Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program* makes it easier for you to receive free medications manufactured by the Operating Companies of Johnson & Johnson.
Where can I find the Johnson&Johnson Prescription Assistance Program?
Click here to visit the program's web site. Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)* is committed to helping you get the prescription medications you need.
Do you qualify for Johnson&Johnson free medications?
If you qualify, the Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program* makes it easier for you to receive free medications manufactured by the Operating Companies of Johnson & Johnson.
What is the jjpaf program?
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, non-profit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. otherwise wouldn’t receive.
See more

How do you qualify for free eliquis?
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS® (apixaban) if:You have not previously filled a prescription for ELIQUIS;You have a valid 30-day prescription for ELIQUIS;You are being treated with ELIQUIS for an FDA-approved indication that an HCP has planned for more than 35 days of treatment;More items...
Is there a patient assistance program for vascepa?
If you are eligible for the Vascepa patient assistance program, the cost of your medication will be free. We only charge $49 a month, per medication, to cover our service fees. You could receive your Vascepa prescription for just $49 a month, regardless of the retail price of your medication.
Does Pfizer have a patient assistance program?
Pfizer RxPathways® patients in need get access to their Pfizer medicines. Today, Pfizer RxPathways® connects eligible U.S. patients to a range of Pfizer assistance programs that provide insurance support, co-pay help, and medicines for free or at a savings.
What is Allergan patient assistance program?
The Allergan Patient Assistance Program (PAP) provides Allergan medicines at no cost to eligible patients. If the patient qualifies, up to a twelve-month eligibility for the requested medication(s) or device(s) is approved for shipment to the patient's licensed prescriber for dispensing.
What OTC is equivalent to Vascepa?
Fish Oil.Lovaza.TriCor.Omega-3 polyunsaturated fatty acids.Trilipix.Lipofen.
What medication is similar to Vascepa?
Are Vascepa and Lovaza the same? Both medications are similar. Vascepa and Lovaza are both omega-3 fatty acid supplements available by prescription to lower triglycerides. Both medicines contain EPA; Lovaza also contains DHA.
Who makes gabapentin?
Pfizer, the world's largest drug maker, pleaded guilty on 13 May to numerous civil and criminal charges for illegally promoting the off-label use of gabapentin (Neurontin). It has agreed to pay a $240m (£136m; €200m) criminal fine and $152m to state and federal healthcare programmes.
Which Pfizer blood pressure medication is being recalled?
The drugs in the Pfizer recall include certain batches of Accupril (quinapril hydrochloride) tablets and Accuretic (quinapril hydrochloride plus hydrochlorothiazide) tablets distributed by Pfizer, as well as two related generic formulations distributed by Greenstone.
Does Viatris have a patient assistance program?
The Viatris Patient Assistance Program provides certain medicines for free to patients with demonstrated financial need. Viatris is committed to helping patients get the treatments they need, when and where they need them.
How do I contact Abbvie?
If you have a question that isn't answered, please call us at 1-800-222-6885.
How do you save on Vascepa?
Fortunately, there are other ways to save long-term on Vascepa treatment, starting with a SingleCare savings card.Use a SingleCare Vascepa coupon. ... Ask the prescriber for a free sample. ... Consider commercial health insurance. ... Consider Medicaid. ... Shop around for the best price.More items...•
Is there a generic version for Vascepa?
On November 5, 2020, Hikma Pharmaceuticals USA launched an AB-rated generic version of Amarin's Vascepa (icosapent ethyl) 1 gram capsules.
How much Vascepa should you take a day?
Dosage and Administration The daily dose of VASCEPA is 4 grams per day taken as either: four 0.5 gram capsules twice daily with food; or as. two 1 gram capsules twice daily with food.
What are the side effects of Vascepa?
Common side effects may include:muscle or joint pain;constipation;swelling of the hands, legs, or feet.gout; or.chest pressure, racing or pounding heartbeats, fluttering in your chest, feeling short of breath.
What is Johnson and Johnson?from jnj.com
At Johnson & Johnson Consumer Health , we are uniquely positioned to help improve personal health by delivering products that are rooted in science and endorsed by professionals. As part of a fast-moving segment of healthcare, we move with speed to keep the pace with our consumers and deliver meaningful solutions. Our iconic skin health, self care and essential health brands help people live healthier lives, every day from their very first day.
What is a pioneer in medical devices?from jnj.com
As pioneers in medical devices, we continually focus on elevating the standard of care—working to expand patient access, improve outcomes, reduce health system costs and drive value. We create smart, people-centered healthcare to help the patients we serve recover faster and live longer and more vibrantly.
How many Janssen products are on the WHO model list?from jnj.com
Eleven Janssen products are on the WHO Model List of Essential Medicines.
What is Janssen's mission?from jnj.com
Janssen is leading efforts to discover and develop innovative therapeutic solutions for people with brain disorders and to eliminate the social stigma about these diseases.
What is AdVac technology?from jnj.com
AdVac ® technology, based on the development and production of adenovirus vectors is introduced. It can be used to develop vaccines against life-threatening infectious diseases such as Ebola.
What is The Patient Assistance Program?from jjpaf.org
(JJPAF) is an independent, non-profit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.
What is Johnson and Johnson Foundation?from jnjfoundation.com
The Johnson & Johnson Foundation is a registered charitable organization that reflects the commitment of the Johnson & Johnson Family of Companies to keeping people well at every age and every stage of life by blending heart, science and ingenuity to profoundly change the trajectory of health for humanity. Funded solely by the Johnson & Johnson ...
What is Johnson and Johnson Center for Health Worker Innovation?from jnjfoundation.com
This includes the Johnson & Johnson Center for Health Worker Innovation founded in 2019 to catalyze efforts to respond to the human resource crisis in global health and build a thriving health workforce. Leveraging a people-first model, the Center focuses on equipping nurses, midwives and community health workers across the globe with the skills, resources and support they need to improve quality of care and strengthen primary and community-based health systems.
What is Johnson and Johnson Impact Ventures?from jnjfoundation.com
One of the Foundation’s initiatives under the Center is Johnson & Johnson Impact Ventures, an innovative finance vehicle designed to address the existing gap in health-focused impact investing by funding social enterprises that support front line health workers.
Are you taking other HIV medications that are not covered in this program?from jjpaf.org
If so, please go to the HarborPath website to access the HarborPath Patient Application.
What is JJPAF in medicine?
JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is JJPAF?
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson. JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is PPA in healthcare?
The Partnership for Prescription Assistance (PPA) helps qualifying U.S. patients without prescription drug coverage get the medicines they need for free or nearly free. PPA offers a single point of access to more than 475 public and private programs, including nearly 200 offered by pharmaceutical companies.
What is Janssen committed to?
Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.
How many Janssen products are on the WHO model list?
Eleven Janssen products are on the WHO Model List of Essential Medicines.
What is Janssen's mission?
Janssen is leading efforts to discover and develop innovative therapeutic solutions for people with brain disorders and to eliminate the social stigma about these diseases.
What is AdVac technology?
AdVac ® technology, based on the development and production of adenovirus vectors is introduced. It can be used to develop vaccines against life-threatening infectious diseases such as Ebola.
What is The Patient Assistance Program?from jjpaf.org
(JJPAF) is an independent, non-profit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.
When did Janssen submit a new drug application?from jnj.com
On October 26, 2020 , Janssen announced that it submitted a supplemental New Drug Application (sNDA) to the FDA to expand the use of XARELTO ® in patients with PAD to include reducing the risk of major thrombotic vascular events, such as heart attack and amputation, in symptomatic patients after recent lower-extremity revascularization (LER).
What is rivaroxaban used for?from janssencarepath.com
Treatment of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Reduction in the Risk of Recurrence of DVT and of PE:In patients with CrCl <30 mL/min, rivaroxaban exposure and pharmacodynamic effects are increased compared to patients with normal renal function. There are limited clinical data in patients with CrCl 15 to <30 mL/min; therefore, observe closely and promptly evaluate any signs or symptoms of blood loss in these patients. There are no clinical data in patients with CrCl <15 mL/min (including patients on dialysis); therefore, avoid the use of XARELTO®in these patients. Discontinue XARELTO®in patients who develop acute renal failure while on treatment.
What is Xarelto used for?from janssencarepath.com
XARELTO®, in combination with aspirin, is indicated to reduce the risk of major thrombotic vascular events (myocard ial infarction, ischemic stroke, acute limb ischemia , and major amputation of a vascular etiology) in patients with peripheral artery disease (PAD), including patients who have recently undergone a lower extremity revascularization procedure due to symptomatic PAD.
What is the name of the medication that is used to treat blood clots?from xarelto-us.com
Clopidogrel (Plavix ® ) Selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) Other medicines to prevent or treat blood clots. Tell your doctor if you take any of these medicines. Ask your doctor or pharmacist if you are not sure if your medicine is one listed above.
What drugs can impair hemostasis?from janssencarepath.com
These include aspirin, P2Y12platelet inhibitors, dual antiplatelet therapy, other antithrombotic agents, fibrinolytic therapy, NSAIDs, selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs).
Can Xarelto be used for triple positive APS?from janssencarepath.com
Increased Risk of Thrombosis in Patients with Antiphospholipid Syndrome:Direct-acting oral anticoagulants (DOACs), including XARELTO®, are not recommended for use in patients with triple-positive antiphospholipid syndrome (APS). For patients with APS (especially those who are triple positive [positive for lupus anticoagulant, anticardiolipin, and anti-beta 2-glycoprotein I antibodies]), treatment with DOACs has been associated with increased rates of recurrent thrombotic events compared with vitamin K antagonist therapy.
What is The Patient Assistance Program?from jjpaf.org
(JJPAF) is an independent, non-profit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.
How to report side effects of prescription drugs?from janssencarepath.com
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Is SIMPONI a Phase 2/3 drug?from janssencarepath.com
In the Phase 2/3 trials in UC evaluating SIMPONI ® -treated patients, no new adverse drug reactions were identified, and the frequency of adverse drug reactions was similar to the safety profile observed in patients with RA, PsA, and AS.
Can you use Simponi with abatacept?from janssencarepath.com
The concomitant use of a TNF blocker and abatacept or anakinra was associated with a higher risk of serious infections; therefore the use of SIMPONI ® in combination with these products is not recommended .
Is SIMPONI a TNF blocker?from janssencarepath.com
TNF-blocking agents, of which SIMPONI ® is a member, have been associated with rare cases of new-onset or ex acerbation of demyelinating disorders, including multiple sclerosis (MS) and Guillain-Barré syndrome. Cases of central demyelination, MS, optic neuritis, and peripheral demyelinating polyneuropathy have rarely been reported with SIMPONI ®. Exercise caution in considering the use of SIMPONI ® in patients with these disorders. Consider discontinuation if these disorders develop.
Can SIMPONI be used for heart failure?from janssencarepath.com
Some cases had a fatal outcome. Exercise caution and monitor patients with heart failure. Discontinue SIMPONI ® if new or worsening symptoms of heart failure appear.
Can TNF blockers cause lupus?from janssencarepath.com
Rarely, people using TNF blockers have developed lupus-like symptoms. Tell your doctor if you have any symptoms such as a rash on your cheeks or other parts of the body, sensitivity to the sun, new joint or muscle pain, becoming very tired, chest pain or shortness of breath, swelling of the feet, ankles, and/or legs.
How many Johnson and Johnson products are available?
Currently, more than 40 different Johnson and Johnson products are available through the program. In addition, more than 20 medicines and other drugs are also available through a retail pharmacy card that the pharmaceutical company offers.
What are some examples of eligibility criteria for J&J?
Examples of some of the other criteria that will be reviewed to determine program eligibility include the medication you are taking, the applicants family size, and other special circumstances. J&J will also need to make the prescription that the patient needs as well, otherwise they will not be able to help. Almost one million doses of medications are being distributed each and every year.
